Y-90 ibritumomab tiuxetan as consolidation following three cycles of fludarabine-cyclophosphamide-rituximab chemoimmunotherapy in patients with relapsed follicular, indolent or mantle-cell lymphoma: A prospective "Dose"-finding study

Von Schilling, Christoph and Schwarz, Kathleen and Hess, Georg and Viardot, Andreas and Sandherr, Michael and Krause, Stefan and Simon, Jan P. and Roethling, Nadine and Peschel, Christian and Schwaiger, Markus and Scheidhauer, Klemens (2007) Y-90 ibritumomab tiuxetan as consolidation following three cycles of fludarabine-cyclophosphamide-rituximab chemoimmunotherapy in patients with relapsed follicular, indolent or mantle-cell lymphoma: A prospective "Dose"-finding study. BLOOD, 110 (11): 3426. 1004A. ISSN 0006-4971

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 11 Dec 2020 09:28
Last Modified: 11 Dec 2020 09:28
URI: https://pred.uni-regensburg.de/id/eprint/31915

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.